In silico evaluation, characterization,and in vitro anticancer activity of curcumin–nimbinloaded nanoformulation in HCT-116 cell lines

The curcumin-nimbin loaded nanosuspension demonstrated promising anticancer activity against HCT 116 cell lines in both <i>in silico</i> and <i>in vitro</i> studies. Further studies are required to evaluate the anticancer effect of curcumin-nimbin loaded nanosupension through clinical and preclinical studies for the progress of potential formulation in the treatment of colorectal cancer.